文献速递脑血管病

卒中神经炎症的快速激活:移动卒中单元获取的血浆与细胞外囊泡

Rapid Activation of Neuroinflammation in Stroke: Plasma and Extracellular Vesicles Obtained on a Mobile Stroke Unit.
PubMed 文献 · Stroke · 2023-02-02

本研究为概念验证性队列研究,在移动卒中单元上超早期采集急性卒中患者血液,分析血浆和细胞外囊泡来源的神经炎症标志物及结局。结果显示,卒中后36至133分钟内神经炎症级联即被激活,且在前2小时快速升高并持续至24小时,早于既往在人体中观察到的时相。

要点

  • 卒中后36分钟内,血浆IL-6、神经丝轻链、UCH-L1和GFAP可升高至正常水平的10倍。
  • 细胞外囊泡中MMP-9、CXCL4、CRP、IL-6、OPN和PECAM1升高。
  • 炎症标志物在最初2小时内快速升高,并持续上升至24小时。

核心结论

  • 神经炎症级联在卒中后36至133分钟内即被激活并快速进展,早于既往在人体中观察到的时相,提示神经炎症所致损伤发生速度比先前推测的更快。
  • 这些发现可为急性免疫调节性卒中治疗方案的开发提供信息,并可能促成新的诊断工具和结局改善。

研究设计与样本

  • 概念验证性队列研究,在移动卒中单元上超早期采集血液,分析急性卒中患者血浆和细胞外囊泡来源的神经炎症标志物及结局。
  • 共分析41名成人,包括2021年8月至2022年4月期间在移动卒中单元上治疗的15例患者,以及26名健康对照用于建立生物标志物参考水平。
  • 患者中位年龄74岁(范围36-97岁),60%为女性,80%为白人。
  • 10例(67%)诊断为卒中,其中8例(53%)确诊,2例可能为短暂性脑缺血发作或经溶栓后卒中未发生;5例为卒中模拟病。
  • 卒中患者初始NIHSS评分中位数11分(范围4-19),6例(75%)接受了tPA(组织型纤溶酶原激活剂)治疗。

主要发现

  • 卒中后36分钟内,血浆IL-6(白细胞介素-6)、神经丝轻链、UCH-L1(泛素C末端水解酶L1)和GFAP(胶质纤维酸性蛋白)升高幅度可达正常水平的10倍。
  • 细胞外囊泡中MMP-9(基质金属蛋白酶-9)、CXCL4(趋化因子(C-X-C基序)配体4)、CRP(C反应蛋白)、IL-6、OPN(骨桥蛋白)和PECAM1(血小板和内皮细胞黏附分子1)升高。
  • 炎症标志物在最初2小时内快速升高,并持续上升至24小时。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Neuroinflammation is ubiquitous in acute stroke and worsens outcome. However, the precise timing of the inflammatory response is unknown, hindering the design of acute anti-inflammatory therapeutic interventions. We sought to identify the onset of the neuroinflammatory cascade using a mobile stroke unit. METHODS: The study is a proof-of-concept, cohort investigation of ultra-early blood- and extracellular vesicle-derived markers of neuroinflammation and outcome in acute stroke. Blood was obtained, prehospital, on an mobile stroke unit. Outcomes were biomarker concentrations, modified Rankin Scale score, and National Institutes of Health Stroke Scale score. RESULTS: Forty-one adults were analyzed, including 15 patients treated on the mobile stroke unit between August 2021 and April 2022, and 26 healthy controls to establish biomarker reference levels. Median patient age was 74 (range, 36-97) years, 60% were female, and 80% White. Ten (67%) were diagnosed as stroke, with 8 (53%) confirmed and 2 likely transient ischemic attack or stroke averted by thrombolysis; 5 were stroke mimics. For strokes, median initial National Institutes of Health Stroke Scale score was 11 (range, 4-19) and 6 (75%) received tPA (tissue-type plasminogen activator). Blood was obtained a median of 58 (range, 36-133) minutes after symptom onset. Within 36 minutes after stroke, plasma IL-6 (interleukin-6), neurofilament light chain, UCH-L1 (ubiquitin C-terminal hydrolase L1), and GFAP (glial fibrillary acidic protein) were elevated by as much as 10 times normal. In EVs, MMP-9 (matrix metalloproteinase-9), CXCL4 (chemokine (C-X-C motif) ligand 4), CRP (C-reactive protein), IL-6, OPN (osteopontin), and PECAM1 (platelet and endothelial cell adhesion molecule 1) were elevated. Inflammatory markers increased rapidly in the first 2 hours and continued rising for 24 hours. CONCLUSIONS: The neuroinflammatory cascade was found to be activated within 36 to 133 minutes after stroke and progresses rapidly. This is earlier than observed previously in humans and suggests injury from neuroinflammation occurs faster than had been surmised. These findings could inform development of acute immunomodulatory stroke therapies and lead to new diagnostic tools and improved outcomes.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Kowalski RG, Ledreux A, Violette JE, et al. Rapid Activation of Neuroinflammation in Stroke: Plasma and Extracellular Vesicles Obtained on a Mobile Stroke Unit. Stroke. 2023. PMID: 36727508. doi:10.1161/STROKEAHA.122.041422

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。